XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating activities:    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 34,534 $ 17,834
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]    
Depreciation and amortization 31,380 31,245
Deferred income taxes and related valuation allowance (783) (1,940)
Net loss (gain) on sale of real estate, investments and other 347 (390)
Stock-based compensation 7,039 8,485
Amortization of deferred financing costs 1,291 1,274
Gain (Loss) on Extinguishment of Debt 0 (14,803)
Unrealized Gain (Loss) on Derivatives (598) 682
Gain (Loss) on Disposition of Property Plant Equipment (232) (375)
Gain (Loss) on Sale of Assets and Asset Impairment Charges (175) 0
Other Operating Activities, Cash Flow Statement 5,814 5,936
Changes in operating assets and liabilities, net of effects of business acquisitions:    
Trade accounts receivable (1,401) 3,931
Inventories (31,701) (42,215)
Prepaid expenses and other 4,905 (5,544)
Increase (Decrease) in Other Operating Assets (232) (298)
Trade accounts payable (18,756) (4,229)
Increase (Decrease) in Accrued Liabilities (7,498) 2,608
Increase (Decrease) in Other Noncurrent Liabilities (7,382) (8,080)
Net cash provided by (used for) operating activities 16,902 23,727
INVESTING ACTIVITIES:    
Proceeds from Sale and Maturity of Marketable Securities 2,650 3,441
Payments to Acquire Marketable Securities (3,121) (6,357)
Payments to Acquire Property, Plant, and Equipment (9,511) (9,506)
Proceeds from Sale of Property, Plant, and Equipment 373 461
Proceeds from Equity Method Investment, Distribution, Return of Capital 313 324
Proceeds from Insurance Settlement, Investing Activities 0 482
Payments to Acquire Businesses, Net of Cash Acquired (1,616) (539,778)
Net cash provided by (used for) investing activities (10,912) (550,933)
FINANCING ACTIVITIES:    
Proceeds from the issuance of common stock 704 2,520
Repayment of debt (30,402) (467,725)
Proceeds from Issuance of Long-term Debt 0 725,000
Payments for Repurchase of Common Stock (1,001) 0
Proceeds from Issuance or Sale of Equity 0 207,000
Stock Issued During Period, Value, Stock Options Exercised 0 (26,184)
Proceeds from Derivative Instrument, Financing Activities 18,422 13,234
Payments for Derivative Instrument, Financing Activities (17,958) (13,687)
Payments of Dividends (6,006) (4,852)
Other (1,398) (2,054)
Net cash provided by (used for) financing activities (37,639) 433,252
Effect of exchange rate changes on cash (2,221) (1,474)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (33,870) (95,428)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents 81,770 106,949
Capital Expenditures Incurred but Not yet Paid 199 161
Supplementary cash flow data:    
Interest Paid, Excluding Capitalized Interest, Operating Activities 18,883 12,687
Income taxes paid, net of refunds 18,486 4,367
Restricted Cash $ 250 $ 250